• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用无标记质谱和鸟枪法蛋白质组学技术鉴定与转移性鼠乳腺肿瘤相关的髓系来源抑制细胞的蛋白质组。

Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics.

机构信息

Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

出版信息

PLoS One. 2011;6(8):e22446. doi: 10.1371/journal.pone.0022446. Epub 2011 Aug 10.

DOI:10.1371/journal.pone.0022446
PMID:21853032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3154190/
Abstract

Expansion of Gr-1+/CD11b+ myeloid derived suppressor cells (MDSCs) is governed by the presence of increasingly metastatic, malignant primary tumors. Metastasis, not the primary tumor, is often the cause of mortality. This study sought to fully characterize the MDSC proteome in response to metastatic and non-metastatic mammary tumors using label-free mass spectrometry shotgun proteomics in a mouse model with tumor cell lines, 67NR and 4T1, derived from the same tumor. 67NR cells form only primary mammary tumors, whereas 4T1 cells readily metastasize to the lungs, lymph nodes, and blood. Overall analysis identified a total of 2825 protein groups with a 0.78% false discovery rate. Of the 2814 true identifications, 43 proteins were exclusive to the 67NR group, 153 were exclusive to the 4T1 group, and 2618 were shared. Among the shared cohort, 26 proteins were increased and 31 were decreased in the metastatic 4T1 cohort compared to non-metastatic 67NR controls after filtering. MDSCs selectively express proteins involved in the γ-glutamyl transferase, glutathione synthase pathways, CREB transcription factor signaling, and other pathways involved in platelet aggregation, as well as lipid and amino acid metabolism, in response to highly metastatic 4T1 tumors. Cell cycle regulation dominated protein pathways and ontological groups of the 67NR non-metastatic group. Not only does this study provide a starting point to identify potential biomarkers of metastasis expressed by MDSCs; it identifies critical pathways that are unique to non-metastatic and metastatic conditions. Therapeutic interventions aimed at these pathways in MDSC may offer a new route to control malignancy and metastasis.

摘要

Gr-1+/CD11b+ 髓系来源抑制细胞(MDSCs)的扩增受不断转移、恶性原发性肿瘤的存在所控制。转移而非原发性肿瘤往往是导致死亡的原因。本研究旨在使用无标签质谱shotgun 蛋白质组学,在具有肿瘤细胞系 67NR 和 4T1 的小鼠模型中,全面表征转移性和非转移性乳腺肿瘤对 MDSC 蛋白质组的影响,这两种细胞系均源自同一肿瘤。67NR 细胞仅形成原发性乳腺肿瘤,而 4T1 细胞则容易转移到肺部、淋巴结和血液中。总体分析共鉴定出 2825 个蛋白组,假发现率为 0.78%。在 2814 个真实鉴定中,有 43 个蛋白仅存在于 67NR 组,153 个蛋白仅存在于 4T1 组,2618 个蛋白是共有的。在共有的队列中,与非转移性 67NR 对照组相比,26 个蛋白在转移性 4T1 队列中增加,31 个蛋白减少。在高度转移性 4T1 肿瘤的刺激下,MDSC 选择性地表达参与 γ-谷氨酰转移酶、谷胱甘肽合酶途径、CREB 转录因子信号转导以及其他与血小板聚集以及脂质和氨基酸代谢相关的途径的蛋白。细胞周期调控主导着 67NR 非转移性组的蛋白途径和本体论组。本研究不仅为鉴定 MDSC 表达的潜在转移标志物提供了一个起点;还鉴定了非转移性和转移性条件下特有的关键途径。针对 MDSC 中这些途径的治疗干预可能为控制恶性肿瘤和转移提供新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/60330acdc11b/pone.0022446.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/23163aa5e321/pone.0022446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/9c77f8048ee5/pone.0022446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/be002084662d/pone.0022446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/2d5c12778b12/pone.0022446.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/60330acdc11b/pone.0022446.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/23163aa5e321/pone.0022446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/9c77f8048ee5/pone.0022446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/be002084662d/pone.0022446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/2d5c12778b12/pone.0022446.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdde/3154190/60330acdc11b/pone.0022446.g005.jpg

相似文献

1
Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics.采用无标记质谱和鸟枪法蛋白质组学技术鉴定与转移性鼠乳腺肿瘤相关的髓系来源抑制细胞的蛋白质组。
PLoS One. 2011;6(8):e22446. doi: 10.1371/journal.pone.0022446. Epub 2011 Aug 10.
2
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.靶向髓源抑制性细胞联合原发性乳腺肿瘤切除术可减少肺部转移生长。
Breast Cancer Res. 2019 Sep 5;21(1):103. doi: 10.1186/s13058-019-1189-x.
3
Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis.鉴定一种抑制转移的髓源抑制细胞半胱氨酸蛋白酶抑制剂样蛋白。
FASEB J. 2011 Aug;25(8):2626-37. doi: 10.1096/fj.10-180604. Epub 2011 Apr 25.
4
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.EO771.LMB肿瘤的功能和分子特征,一种新的源自C57BL/6小鼠的自发性转移性乳腺癌模型。
Dis Model Mech. 2015 Mar;8(3):237-51. doi: 10.1242/dmm.017830. Epub 2015 Jan 29.
5
A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.在小鼠模型中,乳腺癌细胞与髓源性抑制细胞之间的相互激活环通过IL-6转信号促进自发转移。
Breast Cancer Res. 2013;15(5):R79. doi: 10.1186/bcr3473.
6
Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.转移性乳腺癌细胞的代谢可塑性:对微环境变化的适应
Neoplasia. 2015 Aug;17(8):671-84. doi: 10.1016/j.neo.2015.08.005.
7
Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.髓系来源的抑制细胞在肿瘤和器官的浸润。
Int Immunopharmacol. 2011 Jul;11(7):816-26. doi: 10.1016/j.intimp.2011.02.021. Epub 2011 Mar 2.
8
Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.Bcl-2/腺病毒E1B 19 kDa相互作用蛋白-3基因敲低促进乳腺癌在肺、肝和骨中的转移生长。
Cancer Res. 2005 Dec 15;65(24):11689-93. doi: 10.1158/0008-5472.CAN-05-3091.
9
CXCL17-derived CD11bGr-1 myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.CXCL17 衍生的 CD11bGr-1 髓源抑制细胞通过血小板衍生生长因子-BB 促进乳腺癌肺转移。
Breast Cancer Res. 2019 Feb 12;21(1):23. doi: 10.1186/s13058-019-1114-3.
10
Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.组织蛋白酶和 S100A8/A9 的靶向成像反映了恶性肿瘤的特定特征,并能够估计肿瘤的恶性程度。
Mol Imaging Biol. 2020 Feb;22(1):66-72. doi: 10.1007/s11307-019-01370-1.

引用本文的文献

1
Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的患者发生静脉和动脉血栓形成。
PLoS One. 2025 Apr 1;20(4):e0321112. doi: 10.1371/journal.pone.0321112. eCollection 2025.
2
The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape.脂质代谢对乳腺癌的影响:关于其在肿瘤发生和免疫逃逸中作用的综述。
Cell Commun Signal. 2023 Jun 27;21(1):161. doi: 10.1186/s12964-023-01178-1.
3
The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications.

本文引用的文献

1
Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis.鉴定一种抑制转移的髓源抑制细胞半胱氨酸蛋白酶抑制剂样蛋白。
FASEB J. 2011 Aug;25(8):2626-37. doi: 10.1096/fj.10-180604. Epub 2011 Apr 25.
2
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.骨髓来源抑制细胞(MDSC)作为肿瘤逃避舒尼替尼介导的抗血管生成治疗的机制。
Int Immunopharmacol. 2011 Jul;11(7):856-61. doi: 10.1016/j.intimp.2011.01.030. Epub 2011 Feb 11.
3
Less label, more free: approaches in label-free quantitative mass spectrometry.
乳腺癌的代谢格局及其治疗意义。
Mol Diagn Ther. 2023 May;27(3):349-369. doi: 10.1007/s40291-023-00645-2. Epub 2023 Mar 29.
4
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.靶向癌症特异性代谢途径以开发新型癌症治疗方法。
Front Immunol. 2022 Dec 22;13:955476. doi: 10.3389/fimmu.2022.955476. eCollection 2022.
5
All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma.条条大路通组织蛋白酶:组织蛋白酶在非酒精性脂肪性肝炎诱导的肝细胞癌中的作用
Biomedicines. 2022 Sep 21;10(10):2351. doi: 10.3390/biomedicines10102351.
6
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy.靶向肿瘤重编程髓系细胞:癌症免疫治疗的新战场。
Semin Immunopathol. 2023 Mar;45(2):163-186. doi: 10.1007/s00281-022-00965-1. Epub 2022 Sep 26.
7
Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice.脾脏髓源性抑制细胞的光诊疗及其对荷瘤小鼠脾脏代谢的影响
Cancers (Basel). 2022 Jul 22;14(15):3578. doi: 10.3390/cancers14153578.
8
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword.15-脂氧合酶及其代谢产物在乳腺癌发病机制中的作用:一把双刃剑。
Lipids Health Dis. 2021 Nov 27;20(1):169. doi: 10.1186/s12944-021-01599-2.
9
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.接受免疫检查点抑制剂治疗的癌症患者发生血栓栓塞的危险因素、发病率及预后
Front Pharmacol. 2021 Nov 8;12:747075. doi: 10.3389/fphar.2021.747075. eCollection 2021.
10
Thrombotic Complications Associated with Immune Checkpoint Inhibitors.与免疫检查点抑制剂相关的血栓性并发症
Cancers (Basel). 2021 Sep 14;13(18):4606. doi: 10.3390/cancers13184606.
少标签,更自由:无标记定量质谱的方法。
Proteomics. 2011 Feb;11(4):535-53. doi: 10.1002/pmic.201000553. Epub 2011 Jan 17.
4
Myeloid derived suppressor cells in human diseases.髓系来源的抑制细胞在人类疾病中的作用。
Int Immunopharmacol. 2011 Jul;11(7):802-7. doi: 10.1016/j.intimp.2011.01.003. Epub 2011 Jan 13.
5
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.髓系来源的抑制性细胞:抑制抗肿瘤免疫的更多机制。
Cancer Immunol Immunother. 2010 Oct;59(10):1593-600. doi: 10.1007/s00262-010-0855-8. Epub 2010 Apr 23.
6
Subsets, expansion and activation of myeloid-derived suppressor cells.髓系来源抑制细胞的亚群、扩增和激活。
Med Microbiol Immunol. 2010 Aug;199(3):273-81. doi: 10.1007/s00430-010-0151-4. Epub 2010 Apr 8.
7
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.联合组织蛋白酶 B 和组织蛋白酶 Z 缺失对小鼠乳腺癌进展和转移的协同抗肿瘤作用。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502. doi: 10.1073/pnas.0907240107. Epub 2010 Jan 21.
8
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.结直肠癌的亚核蛋白质组学:鉴定富含核基质部分的蛋白质及在腺瘤到癌进展过程中的调控
Mol Cell Proteomics. 2010 May;9(5):988-1005. doi: 10.1074/mcp.M900546-MCP200. Epub 2010 Jan 20.
9
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.在患有侵袭性和癌前性腹腔内肿瘤的小鼠肝脏中,可促进转移的髓样细胞的不同群体扩增。
J Leukoc Biol. 2010 Apr;87(4):713-25. doi: 10.1189/jlb.0909607. Epub 2009 Dec 30.
10
TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.TGM2 是结直肠癌预后和治疗靶点的一个新标志物。
Ann Surg Oncol. 2010 Apr;17(4):967-72. doi: 10.1245/s10434-009-0865-y. Epub 2009 Dec 22.